Related Experiment Video
Updated: Mar 17, 2026

09:54
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
6.2K
Interactions Between Antibody-Coated Iron Micro-Particles and Leukemic Cells as seen by Electron Microscopy
C J Bieva1, R Mosselmans2, F V Brugghen1
1a Dept. Hématologie, Service de Médicine Interne et Laboratoire d'Investigation Clinique H. Tagnon, Brussels, Belgium.
Leukemia & Lymphoma
|July 27, 2016
Summary
Monoclonal antibody-coated microparticles target leukemic cells. CD10 antibody-coated particles penetrate cells at 37°C, offering potential for targeted drug delivery in cancer therapy.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Immunology
Background:
- Monoclonal antibodies (MoAbs) conjugated to ferromagnetic microparticles are used for purging leukemic cells from autografts.
- Previous studies have reported the properties of this reagent for autologous bone marrow transplantation (ABMT).
Purpose of the Study:
- To visualize the interaction between MoAb-coated ferromagnetic microparticles and leukemic cells using electron microscopy.
- To investigate the effect of temperature and incubation time on particle-cell interactions.
Main Methods:
- Transmission electron microscopy was employed to observe interactions.
- A CD10+ NALM6- cell suspension was incubated with CD10 or CD8 MoAb-conjugated particles.
- Incubation occurred over a time course (0-90 min) at 4°C and 37°C.
Main Results:
- CD10 MoAb-particles complexed with the cell surface at 4°C.
- At 37°C, CD10 MoAb-particles readily penetrated leukemic cells.
- CD8 MoAb-particles showed no interaction with cells at either temperature or duration.
Conclusions:
- Temperature-dependent cellular uptake of CD10 MoAb-conjugated microparticles was demonstrated.
- This suggests a potential for site-specific drug delivery by internalizing pharmaceutical agents linked to magnetic carriers.
- The CD8 MoAb-particle interaction was negligible, highlighting the specificity of the CD10-mediated uptake.

